194 related articles for article (PubMed ID: 25995035)
21. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.
Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J
Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340
[TBL] [Abstract][Full Text] [Related]
22. S100A4 expression is associated with poor prognosis in patients with resectable gastrointestinal stromal tumor.
Shen W; Tan X; Hao F
Libyan J Med; 2019 Dec; 14(1):1659669. PubMed ID: 31474194
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of Atoh1 correlates with favorable survival in gastrointestinal stromal tumor.
Huang H; Zhai X; Zhu H; Wang W; Zhang S; Wu L; Zhang J
Int J Clin Exp Pathol; 2014; 7(10):7123-30. PubMed ID: 25400808
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
25. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
26. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
[TBL] [Abstract][Full Text] [Related]
27. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
28. Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry.
Şahin S; Ekinci O; Seçkin S; Dursun A
Pathol Res Pract; 2017 Sep; 213(9):1139-1143. PubMed ID: 28756979
[TBL] [Abstract][Full Text] [Related]
29. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
Song W; Gobe GC
Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
[TBL] [Abstract][Full Text] [Related]
30. Expression of Fatty Acid-Binding Protein-3 in Gastrointestinal Stromal Tumors and Its Significance for Prognosis.
Chen X; Hu SL; Feng Y; Li P; Mao QS; Xue WJ
J Surg Res; 2021 Apr; 260():462-466. PubMed ID: 33272594
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.
Ouyang J; An T; Wang Y; Lu X; Zhang Y; Wang X; Zhang X; Zhang C
Diagn Pathol; 2021 Dec; 16(1):113. PubMed ID: 34895274
[TBL] [Abstract][Full Text] [Related]
32. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
[TBL] [Abstract][Full Text] [Related]
33. MCQs for "Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors".
Darling HS; Jayalakshmi S; Jaiswal P
Indian J Cancer; 2019; 56(2):144-145. PubMed ID: 31062733
[No Abstract] [Full Text] [Related]
34. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of brachyury expression in Ewing sarcoma patients.
Abrahao-Machado LF; Pinto F; Antunes B; Volc S; Boldrini E; Camargo OP; Reis RM
Adv Med Sci; 2021 Sep; 66(2):321-325. PubMed ID: 34273746
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic analysis of gastrointestinal stromal tumors complicated with gastrointestinal bleeding].
Li RT; Zhang GJ; Fu WH; Li WD
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):377-80. PubMed ID: 27188612
[TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stromal tumor: an ultrastructural investigation on regional differences with considerations on their histogenesis.
Min KW
Ultrastruct Pathol; 2010 May; 34(3):174-88. PubMed ID: 20455665
[TBL] [Abstract][Full Text] [Related]
40. Expression of fatty acid-binding protein-4 in gastrointestinal stromal tumors and its significance for prognosis.
Zang WJ; Wang ZN; Hu YL; Huang H; Ma P
J Clin Lab Anal; 2021 Nov; 35(11):e24017. PubMed ID: 34558731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
